Back to Results

Cardlytics Inc (CDLX)

Cardlytics, Inc. is a common stock listed on the NASDAQ exchange under the ticker CDLX. The company operates an advertising platform in the United States and the United Kingdom, with offerings centered on digital marketing and customer engagement. Its Cardlytics platform provides a native bank advertising channel that allows marketers to reach customers through online and mobile environments, email, and real-time notifications. Cardlytics also offers the Bridg platform, a customer data platform that uses point-of-sale information from merchant data partners, including product-level purchase data, to support analytics, targeted loyalty marketing, and campaign measurement. Incorporated in 2008, Cardlytics is headquartered in Atlanta, Georgia.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Dividend Yield Next Earnings Date Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Free Cash Flow / Net Income
NASDAQ-CDLX
$4.33
21.0% Upside
Undervalued
$6
67.6% Upside
Bargain
Weak
0.0%
November 11, 2026
0.1x
21.082 M
183.5 M
89.8%
88.0%
-17.3
-0.4%
Valuation • Fair Value

Cardlytics Inc (NASDAQ-CDLX) Fair Value by Valuation Model

Review the available estimates for Cardlytics Inc (NASDAQ-CDLX), including Comps Fair Value.

Primary Valuation Read

Fair Value

$4.33

Estimated upside of 21.0% versus the current market price.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

Comps Fair Value

$4.33

Comparable-company valuation reference.

Analyst Price Target

$6

Analysts imply upside of 67.6%.

How to read these valuation models

Use the 4 available valuation references for Cardlytics Inc (NASDAQ-CDLX) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Cardlytics Inc (NASDAQ-CDLX)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

190 M

Current operating scale indicator.

Revenue Forecast

148.8 M

Forward revenue estimate.

EBITDA

-13.967 M

Current operating profitability reference.

EBITDA Forecast

4.416 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Cardlytics Inc (NASDAQ-CDLX) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Cardlytics Inc (NASDAQ-CDLX)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Weak

Financial pressure deserves closer review.

Piotroski Score

6

Mid-range quality score.

Beneish M-Score

-5.04

No elevated caution signal from this screen.

Altman Z-Score

-17.3

Lower score that deserves closer risk review.

FCF / Net Income

-0.4%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Cardlytics Inc (NASDAQ-CDLX). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Cardlytics Inc (NASDAQ-CDLX)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

November 11, 2026

Days to Earnings

50

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

This section helps investors track time-sensitive items for Cardlytics Inc (NASDAQ-CDLX), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Cardlytics Inc (NASDAQ-CDLX) Stock Forecast & Technical Outlook

Review Cardlytics Inc (NASDAQ-CDLX) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for Cardlytics Inc (NASDAQ-CDLX) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Cardlytics Inc (NASDAQ-CDLX) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Cardlytics Inc (NASDAQ-CDLX) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Cardlytics Inc (NASDAQ-CDLX) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Cardlytics Inc (NASDAQ-CDLX) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Cardlytics Inc (NASDAQ-CDLX)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Hold

Based on the available recommendation mix, Cardlytics Inc (NASDAQ-CDLX) has a Hold consensus, with 0 buy, 3 hold and 0 sell recommendations in the current data set.

Buy 0
Hold 3
Sell 0
FAQ • Fast Investor Answers

Cardlytics Inc (NASDAQ-CDLX) Stock FAQ

Data-supported answers about Cardlytics Inc (NASDAQ-CDLX), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$4.33
Estimated upside 21.0%
Valuation Rating
Undervalued
Estimated upside of 21.0%
Analyst Target
$6
Implied upside 67.6%
Financial Health
Weak
Current financial-health read

The current fair value estimate for Cardlytics Inc (NASDAQ-CDLX) is $4.33. This implies an estimated upside of 21.0% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 21.0% versus the current market price.

The available analyst price target for Cardlytics Inc (NASDAQ-CDLX) is $6. The analyst target implies estimated upside of 67.6%.

The current financial health read for Cardlytics Inc (NASDAQ-CDLX) is Weak. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Cardlytics Inc (NASDAQ-CDLX) is November 11, 2026.

The latest available data indicates no current dividend yield for Cardlytics Inc (NASDAQ-CDLX).

The current market capitalization listed for Cardlytics Inc is 21.082 M.

The current enterprise value listed for Cardlytics Inc is 183.5 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Cardlytics Inc is NASDAQ-CDLX, and the stock is listed on NASDAQ.

Cardlytics Inc (NASDAQ-CDLX) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for Cardlytics Inc is 89.8%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Cardlytics Inc is 88.0%. Free float helps investors understand how much of the share base is available for public trading.

Similar Media Stocks View more on NASDAQ

Comparable companies from the same industry, limited to one security per issuer.

FOXA NASDAQ Fox Corp Class A Fair Value Fair Market Cap 25.566 B
OMC NYSE Omnicom Group Inc Fair Value Undervalued Market Cap 20.669 B
CHTR NASDAQ Charter Communications Inc Fair Value Bargain Market Cap 19.477 B
NWSA NASDAQ News Corp A Fair Value Fair Market Cap 16.347 B
PSKY NASDAQ Paramount Skydance Corp Fair Value Fair Market Cap 11.343 B
NYT NYSE New York Times Company Fair Value Fair Market Cap 10.556 B
SIRI NASDAQ Sirius XM Holding Inc Fair Value Undervalued Market Cap 8.942 B
TTD NASDAQ The Trade Desk Fair Value Bargain Market Cap 6.231 B
WPP NYSE WPP PLC ADR Fair Value Undervalued Market Cap 5.533 B
NIQ NYSE NIQ Global Intelligence Ltd Fair Value Fair Market Cap 5.297 B
NXST NASDAQ Nexstar Media Group Inc Fair Value Fair Market Cap 5.161 B
VSNT NASDAQ Versant Media Group Inc Fair Value Undervalued Market Cap 4.664 B
MGNI NASDAQ Magnite Inc Fair Value Fair Market Cap 3.557 B
WLY NYSE John Wiley & Sons Fair Value Fair Market Cap 2.384 B
WLYB NYSE John Wiley & Sons B Fair Value Fair Market Cap 2.384 B
STGW NASDAQ Stagwell Inc Fair Value Fair Market Cap 2.08 B
DV NYSE DoubleVerify Holdings Inc Fair Value Undervalued Market Cap 2.077 B
NMAX NYSE Newsmax Inc Fair Value Overvalued Market Cap 1.448 B
CCO NYSE Clear Channel Outdoor Holdings Inc Fair Value Fair Market Cap 1.212 B
TDAY NYSE USA TODAY Co Inc Fair Value Fair Market Cap 955.9 M